[go: up one dir, main page]

HK1185552A1 - Use of interleukin-22 in treating viral hepatitis - Google Patents

Use of interleukin-22 in treating viral hepatitis Download PDF

Info

Publication number
HK1185552A1
HK1185552A1 HK13112981.1A HK13112981A HK1185552A1 HK 1185552 A1 HK1185552 A1 HK 1185552A1 HK 13112981 A HK13112981 A HK 13112981A HK 1185552 A1 HK1185552 A1 HK 1185552A1
Authority
HK
Hong Kong
Prior art keywords
dimer
interleukin
monomer
hepatitis
human interleukin
Prior art date
Application number
HK13112981.1A
Other languages
English (en)
Chinese (zh)
Other versions
HK1185552B (en
Inventor
嚴孝強
严孝强
黃智華
黄智华
楊紅舟
杨红舟
黃予良
黄予良
Original Assignee
健能隆醫藥技術 上海 有限公司
亿一生物医药开发(上海)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 健能隆醫藥技術 上海 有限公司, 亿一生物医药开发(上海)有限公司 filed Critical 健能隆醫藥技術 上海 有限公司
Publication of HK1185552A1 publication Critical patent/HK1185552A1/xx
Publication of HK1185552B publication Critical patent/HK1185552B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK13112981.1A 2010-08-31 2011-08-30 Use of interleukin-22 in treating viral hepatitis HK1185552B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010268320.7 2010-08-31
CN2010102683207A CN102380091A (zh) 2010-08-31 2010-08-31 白介素-22在治疗病毒性肝炎中的应用
PCT/CN2011/079124 WO2012028089A1 (zh) 2010-08-31 2011-08-30 白介素-22在治疗病毒性肝炎中的应用

Publications (2)

Publication Number Publication Date
HK1185552A1 true HK1185552A1 (en) 2014-02-21
HK1185552B HK1185552B (en) 2015-06-19

Family

ID=

Also Published As

Publication number Publication date
WO2012028089A1 (zh) 2012-03-08
US8945528B2 (en) 2015-02-03
US9629898B2 (en) 2017-04-25
ES2658309T3 (es) 2018-03-09
DK2633865T3 (en) 2018-02-26
JP6325585B2 (ja) 2018-05-16
CN103118699B (zh) 2014-11-19
HUE036564T2 (hu) 2018-07-30
US20150202267A1 (en) 2015-07-23
US20130171100A1 (en) 2013-07-04
JP2013536254A (ja) 2013-09-19
CN104479026B (zh) 2019-02-12
JP2016128475A (ja) 2016-07-14
CA2809900C (en) 2018-08-21
TR201802587T4 (tr) 2018-03-21
AU2011298556B2 (en) 2015-04-16
CN103118699A (zh) 2013-05-22
EP2633865A4 (en) 2014-11-12
PL2633865T3 (pl) 2018-05-30
JP5907970B2 (ja) 2016-04-26
AU2011298556A1 (en) 2013-04-04
EP2633865B1 (en) 2017-12-27
CA2809900A1 (en) 2012-03-08
EP2633865A1 (en) 2013-09-04
CN104479026A (zh) 2015-04-01
CN102380091A (zh) 2012-03-21
PT2633865T (pt) 2018-03-13
EP3332798A1 (en) 2018-06-13

Similar Documents

Publication Publication Date Title
JP6325585B2 (ja) インターロイキン−２２のウイルス性肝炎の治療における応用
TWI601744B (zh) 包含調酸素與免疫球蛋白片段之複合物及其用途
ES2332057T3 (es) Muteinas del factor de crecimiento de fibroblastos 21.
CN103547590B (zh) 高度可溶性瘦蛋白
US7112659B2 (en) OB fusion protein compositions and methods
NO325096B1 (no) OB-fusjonsprotein, nukleinsyresekvens, vektor, vertscelle, fremgangsmate for fremstilling av proteinet, farmasoytisk preparat samt anvendelse av proteinet for fremstilling av et terapeutisk preparat.
CN102906120B (zh) 重组人g-csf二聚体及其在治疗神经系统疾病中的用途
TW201900206A (zh) 治療糖尿病或糖胖症之包括調酸素類似物之組成物
JP6825181B2 (ja) 膵炎を治療するための薬剤の製造におけるｉｌ−２２二量体の使用
CN104066440B (zh) 白介素-22在治疗和预防神经损伤疾病或神经退行性疾病中的用途
JP6475698B2 (ja) 組換えマンネンタケ免疫調節タンパク質とヒト血清アルブミンの融合タンパク質及びその製造方法と応用
WO2011147320A1 (zh) B细胞激活因子拮抗剂及其制备方法与用途
HK1185552B (en) Use of interleukin-22 in treating viral hepatitis
HK40002973A (en) An il-22 dimer for use in treating necrotizing enterocolitis
HK40002973B (en) An il-22 dimer for use in treating necrotizing enterocolitis
CN101219208A (zh) 白介素-22的医药用途
HK1223556B (zh) Il-22二聚體在製備用於治療胰腺炎的藥物中的用途
MXPA99001875A (en) Methods of increasing sensitivity of an individual to ob protein by upregulating ob protein receptor